Diagnosis and Treatment > Signs and Symptoms
Search for other papers by Alessandro Mantovani in
Google Scholar
PubMed
Search for other papers by Maddalena Trombetta in
Google Scholar
PubMed
Search for other papers by Chiara Imbriaco in
Google Scholar
PubMed
Search for other papers by Riccardo Rigolon in
Google Scholar
PubMed
Search for other papers by Lucia Mingolla in
Google Scholar
PubMed
Search for other papers by Federica Zamboni in
Google Scholar
PubMed
Search for other papers by Francesca Dal Molin in
Google Scholar
PubMed
Search for other papers by Dario Cioccoloni in
Google Scholar
PubMed
Search for other papers by Viola Sanga in
Google Scholar
PubMed
Search for other papers by Massimiliano Bruti in
Google Scholar
PubMed
Search for other papers by Enrico Brocco in
Google Scholar
PubMed
Search for other papers by Michela Conti in
Google Scholar
PubMed
Search for other papers by Giorgio Ravenna in
Google Scholar
PubMed
Search for other papers by Fabrizia Perrone in
Google Scholar
PubMed
Search for other papers by Vincenzo Stoico in
Google Scholar
PubMed
Search for other papers by Enzo Bonora in
Google Scholar
PubMed
Summary
Vertebral osteomyelitis (or spondylodiscitis) is steadily increasing in Western countries and often results from hematogenous seeding, direct inoculation during spinal surgery, or contiguous spread from an infection in the adjacent soft tissue. We present the case of a 67-year-old white patient with type 2 diabetes who went to Hospital for high fever, back pain, and worsening of known infected ulcers in the left foot. Despite intravenous antibiotic treatment and surgical debridement of the foot infection, high fever and lower back pain continued. Bone biopsy and two consecutive blood cultures were positive for Staphylococcus aureus. A spinal magnetic resonance imaging (MRI) was performed, revealing serious osteomyelitis in L4 and L5 complicated by an epidural abscess. Contiguous or other distant focuses of infection were not identified. In this case, diabetic foot could be considered as a primary distant focus for vertebral osteomyelitis. Clinicians should consider vertebral osteomyelitis as a ‘possible’ diagnosis in patients with type 2 diabetes complicated by foot infection that is associated with fever and lower back pain.
Learning points
-
Vertebral osteomyelitis is increasing in Western countries, especially in patients with type 2 diabetes.
-
The primary focus of infection is the genitourinary tract followed by skin, soft tissue, endocarditis, bursitis, septic arthritis, and intravascular access.
-
Diabetic foot could be a rare primary focus of infection for vertebral osteomyelitis, and, however, vertebral osteomyelitis could be a serious, albeit rare, complication of diabetic foot.
-
Clinicians should keep in mind the many potential complications of diabetic foot ulcerations and consider vertebral osteomyelitis as a “possible” diagnosis in patients with type 2 diabetes and foot ulcers associated with nonspecific symptoms such as lower back pain.
-
Early diagnosis and correct management of vertebral osteomyelitis are crucial to improve clinical outcomes.
Search for other papers by Rossella Mazzilli in
Google Scholar
PubMed
Search for other papers by Michele Delfino in
Google Scholar
PubMed
Search for other papers by Jlenia Elia in
Google Scholar
PubMed
Search for other papers by Francesco Benedetti in
Google Scholar
PubMed
Search for other papers by Laura Alesi in
Google Scholar
PubMed
Search for other papers by Luciana Chessa in
Google Scholar
PubMed
Search for other papers by Fernando Mazzilli in
Google Scholar
PubMed
Summary
We report the case of a 19-year-old boy, presenting several congenital malformations (facial dysmorphisms, cardiac and musculoskeletal abnormalities), mental retardation, recurrent respiratory infections during growth and delayed puberty. Although previously hospitalised in other medical centres, only psychological support had been recommended for this patient. In our department, genetic, biochemical/hormonal and ultrasound examinations were undertaken. The karyotype was 49,XXXXY, a rare aneuploidy with an incidence of 1/85 000–100 000, characterised by the presence of three extra X chromosomes in phenotypically male subjects. The hormonal/biochemical profile showed hypergonadotropic hypogonadism, insulin resistance and vitamin D deficiency. The patient was then treated with testosterone replacement therapy. After 12 months of treatment, we observed the normalisation of testosterone levels. There was also an increase in pubic hair growth, testicular volume and penis size, weight loss, homeostatic model assessment index reduction and the normalisation of vitamin D values. Moreover, the patient showed greater interaction with the social environment and context.
Learning points
-
In cases of plurimalformative syndrome, cognitive impairment, recurrent infections during growth and, primarily, delayed puberty, it is necessary to ascertain as soon as possible whether the patient is suffering from hypogonadism or metabolic disorders due to genetic causes. In our case, the diagnosis of hypogonadism, and then of 49,XXXXY syndrome, was unfortunately made only at the age of 19 years.
-
The testosterone replacement treatment, even though delayed, induced positive effects on: i) development of the reproductive system, ii) regulation of the metabolic profile and iii) interaction with the social environment and context.
-
However, earlier and timely hormonal replacement treatment could probably have improved the quality of life of this subject and his family.